Last checked at 
12 Apr 2022 18:23
Bellevue Healthcare Trust plc (the "Company")
LEI: 213800HQ3J3H9YF2UI82
Share buy-back programme
Bellevue Healthcare Trust plc (the "Company") is amending its disclosure policy to include on a regulatory information services ("RIS") details of its share buyback powers which it renews annually. It is expected similar announcements will be made every time the share buyback authority is renewed.
The Company announces that it has authority to repurchase a maximum of 76,051,083 of its ordinary shares (being its outstanding shareholder authority). Such authority lasts until the next shareholder authority granted, or where expressly revoked by shareholders. The buyback may be funded from the Company's resources (including redemptions on funds the Company has invested in and debt facilities). No maximum consideration payable has been determined by the Company, but the Company is unable to pay a price for any shares pursuant to the buy-back which would equate to a premium on the net asset value.
The Company has appointed J.P. Morgan Securities plc to act as its broker in respect of the buy-back.
The buy-back will be undertaken pursuant the Company's discount management programme.
This arrangement is in accordance with Chapter 12 of the Listing Rules and the Company's general authority to repurchase shares.
Investors are reminded that, as per previous years, the Company intends to offer shareholders the opportunity to redeem their shares at or near NAV at the end of the Company's financial year of 30 November 2022.
For further information please contact:
Bellevue Asset Management (UK) Ltd.
Mark Ghahramani
Telephone: +44 (0) 203 326 2981
J.P. Morgan Cazenove
James Bouverat (Sales)
Telephone: +44 (0) 207 134 2224